| Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse SR Hingorani, EF Petricoin, A Maitra, V Rajapakse, C King, MA Jacobetz, ... Cancer cell 4 (6), 437-450, 2003 | 2806 | 2003 |
| Pancreatic adenocarcinoma, version 2.2017, NCCN clinical practice guidelines in oncology MA Tempero, MP Malafa, M Al-Hawary, H Asbun, A Bain, SW Behrman, ... Journal of the National Comprehensive Cancer Network 15 (8), 1028-1061, 2017 | 981 | 2017 |
| Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology MA Tempero, MP Malafa, M Al-Hawary, SW Behrman, AB Benson, ... Journal of the National Comprehensive Cancer Network 19 (4), 439-457, 2021 | 766 | 2021 |
| Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer JP Morton, P Timpson, SA Karim, RA Ridgway, D Athineos, B Doyle, ... Proceedings of the National Academy of Sciences 107 (1), 246-251, 2010 | 748 | 2010 |
| Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. FR Spitz, JL Abbruzzese, JE Lee, PW Pisters, AM Lowy, CJ Fenoglio, ... Journal of Clinical Oncology 15 (3), 928-937, 1997 | 658 | 1997 |
| Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease AM Lowy, JE Lee, PWT Pisters, BS Davidson, CJ Fenoglio, P Stanford, ... Annals of surgery 226 (5), 632-641, 1997 | 475 | 1997 |
| Left-sided pancreatectomy: a multicenter comparison of laparoscopic and open approaches DA Kooby, T Gillespie, D Bentrem, A Nakeeb, NB Merchant, AA Parikh, ... Annals of surgery 248 (3), 438-446, 2008 | 458 | 2008 |
| β-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer WM Clements, J Wang, A Sarnaik, OJ Kim, J MacDonald, ... Cancer research 62 (12), 3503-3506, 2002 | 457 | 2002 |
| Preoperative modified FOLFIRINOX treatment followed by capecitabine-based chemoradiation for borderline resectable pancreatic cancer: alliance for clinical trials in oncology … MHG Katz, Q Shi, SA Ahmad, JM Herman, RW Marsh, E Collisson, ... JAMA surgery 151 (8), e161137-e161137, 2016 | 444 | 2016 |
| Pancreatic adenocarcinoma, version 2.2014 MA Tempero, MP Malafa, SW Behrman, AB Benson, ES Casper, ... Journal of the National Comprehensive Cancer Network 12 (8), 1083-1093, 2014 | 408 | 2014 |
| An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition L Seguin, S Kato, A Franovic, MF Camargo, J Lesperance, KC Elliott, ... Nature cell biology 16 (5), 457-468, 2014 | 405 | 2014 |
| SWOG S0809: a phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and … E Ben-Josef, KA Guthrie, AB El-Khoueiry, CL Corless, MM Zalupski, ... Journal of Clinical Oncology 33 (24), 2617-2622, 2015 | 397 | 2015 |
| Survival following pancreaticoduodenectomy with resection of the superior mesenteric–portal vein confluence for adenocarcinoma of the pancreatic head SD Leach, JE Lee, C Charnsangavej, KR Cleary, AM Lowy, CJ Fenoglio, ... British Journal of Surgery 85 (5), 611-617, 1998 | 397 | 1998 |
| NCCN guidelines insights: pancreatic adenocarcinoma, version 1.2019: featured updates to the NCCN guidelines MA Tempero, MP Malafa, EG Chiorean, B Czito, C Scaife, AK Narang, ... Journal of the National Comprehensive Cancer Network 17 (3), 202-210, 2019 | 385 | 2019 |
| Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design MHG Katz, R Marsh, JM Herman, Q Shi, E Collison, AP Venook, ... Annals of surgical oncology 20, 2787-2795, 2013 | 365 | 2013 |
| Surgery for pancreatic cancer: recent controversies and current practice CJ Wray, SA Ahmad, JB Matthews, AM Lowy Gastroenterology 128 (6), 1626-1641, 2005 | 359 | 2005 |
| Therapeutic advances in pancreatic cancer AS Paulson, HST Cao, MA Tempero, AM Lowy Gastroenterology 144 (6), 1316-1326, 2013 | 350 | 2013 |
| Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer AM Lowy, PF Mansfield, SD Leach, R Pazdur, P Dumas, JA Ajani Annals of surgery 229 (3), 303-308, 1999 | 347 | 1999 |
| Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring Y Shi, W Gao, NK Lytle, P Huang, X Yuan, AM Dann, M Ridinger-Saison, ... Nature 569 (7754), 131-135, 2019 | 344 | 2019 |
| Sox17 regulates organ lineage segregation of ventral foregut progenitor cells JR Spence, AW Lange, SCJ Lin, KH Kaestner, AM Lowy, I Kim, ... Developmental cell 17 (1), 62-74, 2009 | 340 | 2009 |
